Epic Sciences and Peter Kuhn’s CTC Technology Collaboration Epic Sciences, Inc. has entered into an exclusive license and collaboration agreement with Peter Kuhn, Ph.D., and the USC Michelson Center for Convergent Bioscience. Dr. Kuhn is a founding member...
The Michelson Medical Research Foundation and Human Immunome Project hosted a special 2-hour ceremony with 2020 Michelson Prizes Winners, Dr. Danika Hill (Monash University) and Dr. Michael Birnbaum (MIT). The winners share highlights about their immunology research,...
Even though scientific knowledge about COVID-19 grows by the day, the mysteries of the disease’s progression remain a major hurdle in stemming the pandemic. Researchers at the USC Michelson Center for Convergent Bioscience are helping unlock these secrets...
Spurring Innovation in Human Immunology and Vaccine Research Even as potential vaccine breakthroughs offer hope against COVID-19, scientists also continue making progress on vaccines to combat other diseases. Michelson Medical Research Foundation and the Human...
Scientists around the world are racing to discover a vaccine for COVID-19, with clinical trials fast-tracked as never before. Experts predict that a vaccine could be ready for the public as soon as early 2021—just about a year after the emergence of the novel...